Close
4
Minakem-flap
Minakem-flap

Company profile for XyloCor Therapeutics

Client EmailClient Virtual Booth
XYLOCOR THERAPEUTICS
  • Connect with Us...

PharmaCompass
About the Company
XyloCor Therapeutics is a biopharmaceutical company focused on the development of novel gene therapy for unmet needs in advanced coronary artery disease. In the United States, coronary artery disease is a leading cause of death and disability. Our lead product candidate, XC001, is in clinical development for patients with refractory angina for which there are no treatment options. XyloCor also has a secondary product, XC002, i...
XyloCor Therapeutics is a biopharmaceutical company focused on the development of novel gene therapy for unmet needs in advanced coronary artery disease. In the United States, coronary artery disease is a leading cause of death and disability. Our lead product candidate, XC001, is in clinical development for patients with refractory angina for which there are no treatment options. XyloCor also has a secondary product, XC002, in discovery stage, for patients with cardiac tissue damage from heart attacks.
Upgrade the company profile

Upgrade this company profile// Update & customize all content.
Ask PharmaCompass, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
XyloCor Therapeutics
United_States_of_America Flag
Country
Country
UNITED STATES
Address
Address
--
Telephone
Telephone
888-290-0081
Linkedin
Linkedin
Twitter
Twitter
Client Virtual Booth

Upgrade this company profile// Update & customize all content.
Ask PharmaCompass, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Learn More About